INCYTE CORP
INCYAPI behind this page
INCY Q3 2025 request
Playground key active
/api/financials?ticker=INCY&year=2025&quarter=3
Pick an endpoint and run the request.
Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue | 1,365,980 | 1,137,871 | +20.0% |
Show Product Lines breakouts |
|||
| ICLUSIG | 37,582 | 29,745 | +26.3% |
| JAKAFI | 791,071 | 741,181 | +6.7% |
| JAKAFI · US | 19.3 | 36.3 | -46.8% |
| JAKAVI Royalty Revenues | 125,645 | 115,741 | +8.6% |
| JAKAVI · Novartis | 125.6 | 115.7 | +8.6% |
| Milestone and contract revenues | 45,000 | 18,000 | +150.0% |
| Milestone and contract revenues · Reportable Segment | 45,000 | 18,000 | +150.0% |
| MINJUVI/MONJUVI | 41,990 | 31,439 | +33.6% |
| NIKTIMVO | 45,830 | — | — |
| OLUMIANT Royalty Revenues | 37,111 | 34,796 | +6.7% |
| OLUMIANT · Eli Lilly | 37.1 | 34.8 | +6.6% |
| OPZELURA | 187,968 | 139,272 | +35.0% |
| Other product royalty revenues | 1,855 | 414 | +348.1% |
| PEMAZYRE | 22,741 | 20,661 | +10.1% |
| Product | 1,149,856 | 962,992 | +19.4% |
| Product · Reportable Segment | 1,149,856 | 962,992 | +19.4% |
| Royalty | 171,124 | 156,879 | +9.1% |
| Royalty · Reportable Segment | 171,124 | 156,879 | +9.1% |
| TABRECTA Royalty Revenues | 6,513 | 5,928 | +9.9% |
| TABRECTA · Novartis | 6.5 | 5.9 | +10.2% |
| ZYNYZ | 22,674 | 694 | +3167.1% |
Show Business Segments breakouts |
|||
| Reportable Segment | 1,365,980 | 1,137,871 | +20.0% |
Show Geography breakouts |
|||
| Europe | 100,306 | 66,464 | +50.9% |
| Other countries | 4,413 | 1,367 | +222.8% |
| US | 1,261,261 | 1,070,040 | +17.9% |
| Cost of Revenue | 99,001 | 85,993 | +15.1% |
Show Business Segments breakouts |
|||
| Reportable Segment | 99,001 | 85,993 | +15.1% |
| Research & Development | 506,584 | 573,174 | -11.6% |
Show Type Of Arrangement breakouts |
|||
| Syndax | 6.3 | 5.8 | +8.6% |
| Selling, General & Administrative | 329,081 | 309,209 | +6.4% |
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -12,204 | 23,410 | -152.1% |
Show Business Segments breakouts |
|||
| Reportable Segment | -12,204 | 23,410 | -152.1% |
| Total Costs & Expenses | 922,462 | 991,786 | -7.0% |
| Operating Income | 443,518 | 146,085 | +203.6% |
| Interest Income | 26,781 | 19,266 | +39.0% |
| Interest Expense | -592 | -774 | +23.5% |
| Equity Securities Fv Ni Gain Loss | 8,558 | -12,982 | +165.9% |
| Other Non-Operating Income (Expense) | 4,043 | 4,929 | -18.0% |
| Income Before Taxes | 482,308 | 156,524 | +208.1% |
| Income Tax Expense (Benefit) | 58,139 | 50,068 | +16.1% |
| Net Income | 424,169 | 106,456 | +298.4% |
Show Business Segments breakouts |
|||
| Reportable Segment | 424,169 | 106,456 | +298.4% |
Show Equity Components breakouts |
|||
| Retained Earnings | 424,169 | 106,456 | +298.4% |
| EPS (Basic) | 2.17 | 0.55 | +294.5% |
| EPS (Diluted) | 2.11 | 0.54 | +290.7% |
| Wtd Avg Shares (Basic) | 195,670 | 192,629 | +1.6% |
| Wtd Avg Shares (Diluted) | 201,429 | 195,838 | +2.9% |
| Sales & Marketing (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 272,302 | 241,880 | +12.6% |
| General & Administrative (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Reportable Segment | 56,779 | 67,329 | -15.7% |
| Comprehensive Income | 425,285 | 127,531 | +233.5% |
| Other Comprehensive Income | 1,116 | 21,075 | -94.7% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | 1,116 | 21,075 | -94.7% |
| Net Income Loss Available To Common Stockholders Basic | 424,169 | 106,456 | +298.4% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 2,455,006 | 1,304,109 | +88.3% |
| Debt Securities Available For Sale Excluding Accrued Interest Current | 474,814 | — | — |
| Accounts Receivable Net | 895,890 | 758,450 | +18.1% |
| Inventory | 83,447 | 70,442 | +18.5% |
| Prepaid Expenses & Other Current Assets | 368,732 | 205,128 | +79.8% |
| Total Current Assets | 4,277,889 | 2,808,708 | +52.3% |
| Non-Current Assets | |||
| Restricted Cash Noncurrent | 1,843 | 1,737 | +6.1% |
| Equity Securities F V N I Noncurrent | 21,870 | — | — |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 21,870 | — | — |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Investment in Syndax | 21.9 | — | — |
Show Fair Value By Measurement Basis breakouts |
|||
| Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring | 21,870 | — | — |
| Inventory Noncurrent | 366,510 | 297,974 | +23.0% |
| Property, Plant & Equipment | 798,634 | — | — |
Show Geography breakouts |
|||
| CH | 308,107 | — | — |
| Other countries | 13,468 | — | — |
| US | 477,059 | — | — |
| Goodwill | 155,593 | 155,593 | 0.0% |
| Deferred Tax Assets | 528,138 | 762,310 | -30.7% |
| Other Non-Current Assets | 32,303 | 40,378 | -20.0% |
| Total Assets | 6,330,356 | 5,012,434 | +26.3% |
| Other Assets | |||
| Finance Lease Right Of Use Asset | 28,155 | 25,072 | +12.3% |
| Other Intangible Assets Net | 119,421 | 119,994 | -0.5% |
| Current Liabilities | |||
| Accounts Payable | 171,925 | 178,710 | -3.8% |
| Employee Related Liabilities Current | 168,250 | 150,722 | +11.6% |
| Accrued Liabilities | 948,439 | 1,127,951 | -15.9% |
| Finance Lease Liability Current | 4,491 | 3,932 | +14.2% |
| Business Combination Contingent Consideration Liability Current | 45,624 | 40,335 | +13.1% |
| Total Current Liabilities | 1,338,729 | 1,501,650 | -10.8% |
| Non-Current Liabilities | |||
| Business Combination Contingent Consideration Liability Noncurrent | 138,376 | 166,665 | -17.0% |
| Finance Lease Liability Noncurrent | 30,881 | 28,223 | +9.4% |
| Other Non-Current Liabilities | 171,176 | 144,676 | +18.3% |
| Total Liabilities | 1,679,162 | 1,841,214 | -8.8% |
| Stockholders' Equity | |||
| Common Stock | 196 | 192 | +2.1% |
| Additional Paid In Capital Common Stock | 4,721,953 | 4,429,466 | +6.6% |
| Accumulated Other Comprehensive Income | 14,555 | 15,655 | -7.0% |
| Retained Earnings | -85,510 | -1,274,093 | +93.3% |
| Total Stockholders' Equity | 4,651,194 | 3,171,220 | +46.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -38,251 | -29,655 | -29.0% |
| Accumulated Net Unrealized Investment Gain Loss | 1,688 | 3,314 | -49.1% |
| Accumulated Other Comprehensive Income | 14,555 | 15,655 | -7.0% |
| Accumulated Translation Adjustment | 51,118 | 41,996 | +21.7% |
| Additional Paid In Capital | 4,721,953 | 4,429,466 | +6.6% |
| Common Stock | 196 | 192 | +2.1% |
| Retained Earnings | -85,510 | -1,274,093 | +93.3% |
| Total Liabilities & Equity | 6,330,356 | 5,012,434 | +26.3% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Net Income | 987,371 | -168,597 | +685.6% |
| Depreciation & Amortization | 69,304 | 66,515 | +4.2% |
| Stock-Based Compensation | 187,189 | 194,340 | -3.7% |
| Increase Decrease In Deferred Income Taxes | 234,188 | -85,609 | +373.6% |
| Other Non-Cash Items | 3,445 | -4,824 | +171.4% |
| Change in Accounts Receivable | -42,275 | -14,893 | -183.9% |
| Change in Prepaid & Other Assets | -221,275 | -55,381 | -299.6% |
| Change in Inventory | -53,654 | -93,352 | +42.5% |
| Change in Accounts Payable | -26,414 | 69,109 | -138.2% |
| Increase Decrease In Accrued Liabilities | -286,747 | 149,170 | -292.2% |
| Net Cash from Operations | 870,197 | -45,881 | +1996.6% |
| Investing Activities | |||
| Proceeds From Sale Of Longterm Investments | 8 | 282,866 | -100.0% |
| Payments To Acquire Other Productive Assets | -36,990 | -68,879 | +46.3% |
| Payments To Acquire Intangible Assets | -25,000 | -13,900 | -79.9% |
| Payments To Acquire Marketable Securities | -212,852 | -228,986 | +7.0% |
| Proceeds From Sale And Maturity Of Marketable Securities | 209,643 | 207,881 | +0.8% |
| Net Cash from Investing | -65,191 | 178,982 | -136.4% |
| Financing Activities | |||
| Payments For Repurchase Of Common Stock Excise Tax | -19,100 | — | — |
| Proceeds From Stock Plans | 61,553 | 16,242 | +279.0% |
| Tax Withholding for Share Compensation | -60,469 | -39,416 | -53.4% |
| Finance Lease Principal Payments | -3,386 | -2,761 | -22.6% |
| Payment Of Contingent Consideration | -15,298 | -11,216 | -36.4% |
| Net Cash from Financing | -36,700 | -2,041,941 | +98.2% |
| Supplemental | |||
| Income Taxes Paid | 185,221 | 302,860 | -38.8% |
| Loss Contingency Accrual Payments | 294,881 | — | — |
| Unpaid Capital Expenditures | 4,158 | 3,538 | +17.5% |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 3,163 | 2,436 | +29.8% |
| Right Of Use Asset Obtained In Exchange For Finance Lease Liability | 438 | 1,959 | -77.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -908 | -535 | -69.7% |
| Net Change in Cash | 767,398 | -1,909,375 | +140.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2,456,849 | 1,305,846 | +88.1% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.